Cyclin dependent kinase 4/6 (CDK4/6) inhibitors, in combination with MAPK inhibitors, induced senescence in lung and pancreatic cancer mouse models, and the SASP contributed to a potent antitumor immune response68,69. Here, CDK4 is linked to familial pancreatic carcinoma.